10 results
Glucose-lowering medication in type 2 diabetes - Algorithm

#Diabetes #Medications #Algorithm #Pharmacology #Pharmacotherapy #Hypoglycemic #Management #Endocrinology
Glucose-lowering medication ... Diabetes #Medications ... #Algorithm #Pharmacology ... #Hypoglycemic #Management ... #Endocrinology
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
of Antidiabetic Medications ... - AACE 2018 ... #Antidiabetic #Medications ... #Endocrinology ... #Pharmacology #Management
AACE/ACE 2018 Glycemic Control Algorithm

#AACE #2018 #Glycemic #Diabetes #DM2 #Control #Medication #Algorithm #Endocrinology #PrimaryCare #Management
#AACE #2018 # ... Glycemic #Diabetes ... #DM2 #Control #Medication ... #Algorithm #Endocrinology ... #PrimaryCare #Management
Diabetes Medication Choice
-Diabetes Medication Choice decision aid cards provide information on medications commonly used to treat
Diabetes Medication ... Medication Choice ... information on medications ... . ** 2018 grepmed ... images/2507 #Management
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... Each class of medications ... #pharmacology #pharmacotherapy ... #management #medications ... #diabetes #endocrinology
Pharmacologic treatment of hyperglycemia in adults with type 2 diabetes

#Diabetes #Management #Algorithm #endocrinology #pharmacology #medications
Pharmacologic treatment ... #Diabetes #Management ... #Algorithm #endocrinology ... #pharmacology # ... medications
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... Medication Guide ... #Medications #pharmacology ... #comparison #table ... #endocrinology
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
medications, with ... being approved in 2013 ... SGLT2 #Inhibitors #Pharmacology ... #Medications #DM2 ... #Diabetes #Endocrinology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
different than other medications ... very tolerable medication ... Renal #Dosing #Pharmacology ... #Management #Diabetes ... #DM2 #Endocrinology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Does the patient ... - Allergies to medications ... event, follow ACC algorithm ... Diabetes regimen ... medical and surgical management